MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0011705
Mars Therapeutics Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹60.85 Cr
▲ 25% YoY
Net profit · FY 2025
₹2.46 Cr
Net margin 4.1%
EBITDA · FY 2025
₹4.94 Cr
EBITDA margin 8.1%
Authorised capital
₹14.25 Cr
Registered with MCA
Paid-up capital
₹13.88 Cr
Issued & subscribed
Open charges
₹21 Cr
Satisfied ₹44.05 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
153
Provident fund records
About Mars Therapeutics Private Limited
Data last updated:
Mars Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 March 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG1993PTC015547. Its GSTIN is 36AABCM3914D1ZV (Telangana). The company holds 9 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹14.25 Cr and a paid-up capital of ₹13.88 Cr. It was formerly known as Mars Therapeutics and Chemicals Ltd and Mars Therapeutics and Chemicals Private Ltd. It is led by directors Rajasekhar Pullela (Managing Director) and Apparao Pullela (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4 – 4 – 1/2 D.Pochampally Dundigal – Gandimaisamma Mandal Medchal Malkajgiri District, Hyderabad, Telangana, India – 500043.
As per the financials filed for FY 2025, the company reported a revenue of ₹60.85 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹2.46 Cr (net margin 4.1%) and EBITDA of ₹4.94 Cr (EBITDA margin 8.1%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years.
The company has about 153 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹21 Cr and satisfied charges of ₹44.05 Cr on record. Court records list 32 cases involving the company, including 16 filed by the company and 16 filed against it; 18 cases are pending.
Mars Therapeutics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0011705). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website marspharma.com.
Company details
CIN U24239TG1993PTC015547
Registration Number 015547
Incorporation Date 29 March 1993
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0011705
Name history
Mars Therapeutics has undergone 4 name changes throughout its history. The current legal name is Mars Therapeutics Private Limited.
| Company Name | Status |
|---|---|
| Mars Therapeutics Private Limited | Current |
| Mars Therapeutics And Chemicals Ltd | Previous |
| Mars Therapeutics And Chemicals Private Ltd | Previous |
| Mars Therapeutics & Chemicals Limited | Previous |
| Mars Therapeutics & Chemicals Private Limited | Previous |
CIN history
Mars Therapeutics has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239TG1993PTC015547, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG1993PTC015547 | Current |
| U24239AP1993PLC015547 | Previous |
| U24239TG1993PLC015547 | Previous |
Recognitions & Rankings of Mars Therapeutics
Contact details
Mars Therapeutics Private Limited's registered office is in Hyderabad, Telangana. Its website is marspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address4 – 4 – 1/2 D.Pochampally Dundigal – Gandimaisamma Mandal Medchal Malkajgiri District, Hyderabad, Telangana, India – 500043
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mars Therapeutics Private Limited, buy the company report.
Comprehensive company report
Mars Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Mars Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mars Therapeutics Private Limited, buy the company report.
Financials of Mars Therapeutics Private Limited
FY 2025 filings availableMars Therapeutics Private Limited reported revenue of ₹60.85 Cr (up 25% YoY) for FY 2025.
Revenue · FY 2025
₹60.85 Cr ▲ 25%
Net profit · FY 2025
₹2.46 Cr margin 4.1%
EBITDA · FY 2025
₹4.94 Cr margin 8.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 9%
Revenue has grown at a compounded annual rate (CAGR) of 11% over three years, including 25% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.94 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.46 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.1% | ||||
| Net Profit Margin | 4.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mars Therapeutics Private Limited, buy the company report.
Board of directors of Mars Therapeutics Private Limited
Mars Therapeutics has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Apparao Pullela Also directs: Mars Pharma Private Limited | Whole-Time Director | 09 Dec 2019 | 6 Years 10 Months | Current |
| Rajasekhar Pullela Also directs: Mars Pharma Private Limited | Managing Director | 15 Oct 2012 | 14 Years 0 Months | Current |
Peer comparison
Mars Therapeutics Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mistair Health and Hygiene Private Limited | ₹61.27 Cr (FY 2025) | -21.0% | Mumbai, Maharashtra, India | |||
| Gentech Healthcare Private Limited | ₹61.04 Cr (FY 2025) | 15.0% | New Delhi, Delhi, India | |||
| Mars Therapeutics Private Limitedthis company | ₹60.85 Cr (FY 2025) | ₹2.46 Cr | 4.1% | 25.0% | 153 | Hyderabad, Telangana, India |
| Yacca Lifesciences Private Limited | ₹60.81 Cr (FY 2024) | 39.0% | Roorkee, Uttarakhand, India | |||
| Kausikh Therapeutics Private Limited | ₹60.69 Cr (FY 2025) | 8.0% | Gerugambakkam, Tamil Nadu, India |
To see the full peer comparison of Mars Therapeutics Private Limited, buy the company report.
Auditor
Mars Therapeutics Private Limited is audited by SANJEEVA RAO & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJEEVA RAO & ASSOCIATES | FY 2024 | 010833S |
Shareholding
The shareholding of Mars Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mars Therapeutics Private Limited, buy the company report.
Charges & borrowings
Open charges
₹21 Cr
Satisfied charges
₹44.05 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jun 2025 | 101120684 | Canara Bank | ₹10 Cr | Open | |
| 22 Oct 2024 | 101003868 | Canara Bank | ₹3 Cr | Open | |
| 22 Oct 2024 | 101004257 | Canara Bank | ₹8 Cr | Open | |
| 27 Dec 2022 | 100659499 | Others | ₹2 Cr | Satisfied | |
| 22 Nov 2022 | 100644091 | Others | ₹5.4 Cr | Satisfied |
To see the full charge records of Mars Therapeutics Private Limited, buy the company report.
Total charge records: 19 View all charges
Legal cases
Mars Therapeutics Private Limited has 32 court cases on record: 16 filed by Mars Therapeutics, 16 filed against it. 18 cases are pending and 14 are disposed.
Total cases
32
Filed by the company
16
Filed against the company
16
Pending
18
Disposed
14
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 19 | 5 | 7 |
| District courts | 11 | 11 | 11 |
| Supreme Court | 2 | 0 | 0 |
Cases on record (5 of 32)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (1511MISC-Criminal Law : Criminal matters other than covered by the aforesaid categories(SLPs arising out of quashing applications, orders framing charge, summoning orders, interim orders in criminal matters, withdrawal of prosecution, orders for further investigation/re-investigation etc.) | Filed by the company against The State of Telangana and 5 others | Disposed |
| District court, South, Delhi | Cheque dishonour complaint | Filed against the company by Godrej Finance Limited | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by Krazybee Services Private Limited | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by Kisetsu Saison Finance India P. Ltd. | Pending |
| Bombay High Court | Arbitration matter | Filed against the company by Arka Fincap Limited Through Tejas Ulhas Thik | Pending |
To see the full case history of Mars Therapeutics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Mars Therapeutics Private Limited was last rated by Crisil on 17 Jun 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 17 Jun 2020 |
To see the full credit ratings and regulatory alerts of Mars Therapeutics Private Limited, buy the company report.
MSME payment delays
Mars Therapeutics Private Limited has 4 MSME Form 1 returns on record between 2019 and 2021, listing 113 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 15)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Vidhata Pharma Services | |||
| Dots Lifescience Private Limited | |||
| Unikap Technologies | |||
| Vibrant Foils & Prints | |||
| an individual supplier |
To see the full MSME payment records of Mars Therapeutics Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Mars Therapeutics Private Limited has a workforce of 153 employees on its EPFO records as of Feb 27, 2025, across 1 active EPFO establishment.
Employee count
153
Active EPFO establishments
1
Employee growth
0.66%
GST
Mars Therapeutics has 9 GST registrations: 1 active and 8 cancelled or inactive.
Total GSTINs
9
Active
1
Cancelled / inactive
8
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCM3914D1ZV | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mars Therapeutics Private Limited, buy the company report.
Recent activity
Mars Therapeutics Private Limited has 9 board changes on record since 2012: 2 appointments and 7 cessations. The latest: Vasundhara Devi Pullela ceased to be Director on 08 Sep 2021.
AGM
Mars Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Canara Bank amounted to Rs. 10.00 Cr with Charge ID 101120684 was registered on 21 Jun 2025.
Filing
Mars Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge registered on 27 Feb 2020 via Charge ID 100340511 with Axis Bank Limited was fully satisfied on 11 Feb 2025.
Charges
A charge registered on 22 Nov 2022 via Charge ID 100644091 with Others was fully satisfied on 08 Nov 2024.
Charges
A charge registered on 13 Jun 2022 via Charge ID 100585265 with Others was fully satisfied on 08 Nov 2024.
Charges
A charge registered on 23 Mar 2022 via Charge ID 100559548 with Others was fully satisfied on 08 Nov 2024.
Charges
A charge registered on 04 Nov 2020 via Charge ID 100395517 with Others was fully satisfied on 08 Nov 2024.
Charges
A charge with Canara Bank amounted to Rs. 3.00 Cr with Charge ID 101003868 was registered on 22 Oct 2024.
Charges
A charge with Canara Bank amounted to Rs. 8.00 Cr with Charge ID 101004257 was registered on 22 Oct 2024.
Charges
A charge registered on 27 Dec 2022 via Charge ID 100659499 with Others was fully satisfied on 21 Mar 2024.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100659499 was registered on 27 Dec 2022.
38 earlier events are in the company report.
Frequently asked questions
Mars Therapeutics is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 March 1993 (33+ years old) and is registered under CIN U24239TG1993PTC015547.
Mars Therapeutics has 2 current directors:
- Rajasekhar Pullela - Managing Director
- Apparao Pullela - Whole-Time Director
The latest financial statements of Mars Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mars Therapeutics is 36AABCM3914D1ZV, registered in Telangana. The company has 9 GST registrations in all, of which 1 is active and 8 are cancelled or inactive.
The CIN (Corporate Identification Number) of Mars Therapeutics is U24239TG1993PTC015547. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mars Therapeutics has 32 court cases on record: 16 filed by the company and 16 filed against it. 18 are pending. Most are in the high courts.
Mars Therapeutics was incorporated on 29 March 1993, making it 33+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Mars Therapeutics by revenue are Mistair Health and Hygiene Private Limited, Gentech Healthcare Private Limited, Yacca Lifesciences Private Limited, Kausikh Therapeutics Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vasundhara Devi Pullela ceased to be Director on 08 Sep 2021. Vikas Kumar Gouru ceased to be Company Secretary on 29 Jun 2021. Apparao Pullela ceased to be Additional Director on 31 Dec 2020. Mars Therapeutics has 9 board changes on record in total.
Yes, Mars Therapeutics is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0011705).
Mars Therapeutics has 4 MSME Form 1 returns on record between 2019 and 2021, listing 113 overdue payments to 15 micro and small suppliers. The latest return was filed on 28 Jun 2021.
Mars Therapeutics can be reached through the website marspharma.com. Its registered office is in Hyderabad, Telangana, India.